Cargando…
FAM225A promotes sorafenib resistance in hepatocarcinoma cells through modulating miR-130a-5p–CCNG1 interaction network
Chemotherapy resistance is still a key hurdle in current hepatocellular carcinoma (HCC) treatment. Therefore, clarifying the molecular mechanisms contributing to this acquired resistance is urgent for the effective treatment of liver cancer. In this research, we observed that lncRNA FAM225A expressi...
Autores principales: | Liu, Yan-Tong, Liu, Guo-Qing, Huang, Jing-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744609/ https://www.ncbi.nlm.nih.gov/pubmed/33245102 http://dx.doi.org/10.1042/BSR20202054 |
Ejemplares similares
-
FAM225A facilitates colorectal cancer progression by sponging miR‐613 to regulate NOTCH3
por: Zhang, Xuexiu, et al.
Publicado: (2020) -
Exosomal lncRNA FAM225A accelerates esophageal squamous cell carcinoma progression and angiogenesis via sponging miR‐206 to upregulate NETO2 and FOXP1 expression
por: Zhang, Chunyu, et al.
Publicado: (2020) -
miR-1246 Targets CCNG2 to Enhance Cancer Stemness and Chemoresistance in Oral Carcinomas
por: Lin, Shih-Shen, et al.
Publicado: (2018) -
miR-23b suppresses lung carcinoma cell proliferation through CCNG1
por: Han, Hongsheng, et al.
Publicado: (2018) -
miR-23b suppresses lung carcinoma cell proliferation through CCNG1
por: Han, Hongsheng, et al.
Publicado: (2019)